Breast Cancer

Physician assistant Casey Swanson responds to a question about cancer risk and genetic testing for a BRCA2 mutation.

Andrea Beckendorf's decision to get breast cancer screening despite the COVID-19 pandemic led to an early diagnosis of treatable breast cancer.

Research by Antonio Forte, M.D., Ph.D., a Mayo Clinic plastic surgeon, seeks to better pinpoint who is most likely to benefit from surgery aimed at regenerating a faulty lymphatic system.

When Lisa Pitre went in for a routine mammogram in summer 2019, nothing on her imaging was concerning. By October Lisa was diagnosed with stage 4 invasive lobular carcinoma, an aggressive type of breast cancer.

October holds a bit more significance these days for Michelle Couchenour. It's a time of year to raise awareness for breast cancer, especially since Michelle is not far removed from her initial diagnosis, treatment and recovery.

An article published in the October issue of Mayo Clinic Proceedings offers recommendations regarding supplemental screening for women with dense breast tissue.

Only a small percentage of women are considered to be at high risk for developing breast cancer due to family history, genetic mutation, or tissue-based findings that elevate their odds.

Sen. Amy Klobuchar held a press conference at Mayo Clinic in Rochester, Minnesota, on Oct. 14 to promote the use of preventive health services and emphasize the importance of breast cancer screening.

The findings of the CARRIERS Consortium study, which were published Wednesday, Jan. 20, 2021 in The New England Journal of Medicine, may allow health care[...]

Research from Mayo Clinic investigators presented at the 2019 San Antonio Breast Cancer Symposium suggests that some women with an elevated risk of developing breast[...]